# Adjuvant AI Combined With Zoladex

> **NCT01352091** · PHASE3 · UNKNOWN · sponsor: **Fudan University** · enrollment: 670 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Zoladex+AI
- **DRUG:** TAM

## Key facts

- **NCT ID:** NCT01352091
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-05
- **Primary completion:** 2015-05
- **Final completion:** 2018-04
- **Target enrollment:** 670 (ESTIMATED)
- **Last updated:** 2011-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01352091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01352091, "Adjuvant AI Combined With Zoladex". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01352091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*